2 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Withdrawn 2 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Malabsorption Syndromes: new trials by email Literature Review of Malabsorption Syndromes trials Research Report on Malabsorption Syndromes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Guselkumab in Adult Participants With Celiac Disease Guselkumab, Placebo - Celiac Disease | Phase 1 | Withdrawn | Janssen Research & Development, LLC | 2021-06-17 | 2025-02-03 | |
| Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease Lovaza (omega-3-acid ethyl ester), Corn oil - Liver Disease, Short Bowel Syndrome | Phase 1 / Phase 2 | Withdrawn | Boston Children's Hospital | 2011-01-01 | 2017-06-22 |
Celiac Disease (1) · Liver Diseases (1) · Short Bowel Syndrome (1)
Digestive System Diseases (2) · Gastrointestinal Diseases (2) · Intestinal Diseases (2) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Postoperative Complications (1)
Corn Oil (1) · Fish Oils (1) · Omacor (1) · guselkumab (1)
Boston Children's Hospital (1) · Janssen Research & Development, LLC (1)
United States (2)